Crinetics Pharmaceuticals, Inc.

Bank of New York Mellon Corp CRNX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

405,010

Value ($000)

18,853

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	18,853	0.0%	405,010	12/31/2025
2025 Q3	11/3/2025	16,645	0.0%	399,634	9/30/2025
2025 Q2	8/5/2025	9,949	0.0%	345,928	6/30/2025
2025 Q1	4/29/2025	11,557	0.0%	344,579	3/31/2025
2024 Q4	2/4/2025	17,628	0.0%	344,765	12/31/2024
2024 Q3	11/12/2024	15,940	0.0%	311,940	9/30/2024
2024 Q2	7/25/2024	17,309	0.0%	386,450	6/30/2024
2024 Q1	4/25/2024	13,878	0.0%	296,478	3/31/2024
2023 Q4	1/29/2024	11,726	0.0%	329,579	12/31/2023
2023 Q3	10/24/2023	14,633	0.0%	492,047	9/30/2023
2023 Q2	8/3/2023	8,351	0.0%	463,418	6/30/2023
2023 Q1	5/9/2023	6,790	0.0%	422,789	3/31/2023
2022 Q4	2/14/2023	6,437	0.0%	351,759	12/31/2022
2022 Q3	11/14/2022	6,706	0.0%	341,482	9/30/2022
2022 Q2	8/15/2022	6,177	0.0%	331,245	6/30/2022
2022 Q1	5/11/2022	6,958	0.0%	317,037	3/31/2022
2021 Q4	2/11/2022	9,163	0.0%	322,506	12/31/2021
2021 Q3	11/18/2021	6,365	0.0%	302,345	9/30/2021
2021 Q2	8/11/2021	5,507	0.0%	292,155	6/30/2021
2021 Q1	5/13/2021	4,378	0.0%	286,577	3/31/2021
2020 Q4	2/9/2021	3,848	0.0%	272,637	12/31/2020
2020 Q3	11/12/2020	2,778	0.0%	177,312	9/30/2020
2020 Q2	8/12/2020	3,252	0.0%	185,623	6/30/2020
2020 Q1	5/6/2020	529	0.0%	36,032	3/31/2020
2019 Q4	2/14/2020	899	0.0%	35,847	12/31/2019